Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML
Status:
Recruiting
Trial end date:
2028-03-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the efficacy and safety of venetoclax combined with
homoharringtonine and cytarabine in the treatment of newly diagnosed acute myeloid leukemia.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University